COEP - Coeptis Therapeutics Company Long-Term Liabilities

Public company logo of coeptistx.com (COEP)

This daily price chart for Coeptis Therapeutics (COEP) illustrates the dynamics of debt obligations, which currently stand at 0.00. Coeptis Therapeutics (COEP) is utilizing its existing reserves to drive innovation, as commercial revenue is currently absent. The business is implementing automation in NK-cell cultivation to eliminate human error risk. The enterprise's success depends on medical trial results and access to venture capital for the development of cellular technologies.

Coeptis Therapeutics (COEP) Company Long-Term Debt: for the period 04/28/2023 - 05/09/2026

Coeptis Therapeutics, Inc. (COEP) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price Coeptis Therapeutics Inc.|COEP - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation Coeptis Therapeutics|COEP - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share Coeptis Therapeutics|COEP - Company Book Value|Market Value to Book Value coeptistx.com|COEP - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Coeptis Therapeutics|COEP - Long-Term Debt to Capital|Short-Term Debt to Equity Coeptis Therapeutics Inc.|COEP - Company Debts|Debt to Book Capitalization Ratio Coeptis Therapeutics|COEP - Company Long-Term Debt|Short-Term Debt Coeptis Therapeutics|Immediate Liquidity coeptistx.com
- earnings and market multiples details:
COEP - Net Profit
Analysis of all company metrics:Coeptis Therapeutics (COEP)
Brand item of Coeptis Therapeutics Inc.

Fundamental asset selection requires strict control of debt load to assess the issuer's financial stability. This indicator aggregates confirmed loan and bond obligations with maturities exceeding one year, allowing for an assessment of the cost of bioscreening robotization at Coeptis Therapeutics (COEP) through the business's current level of long-term borrowed capital.

Competitors of Coeptis Therapeutics (COEP)

TGTX: Company Long-Term Indebtedness|Arcellx, Inc. - Company Long-Term Debts|Disc Medicine Inc (IRON) - Company Long-Term Liabilities|SNDX: Company Long-Term Debts|Long-Term Debt Kura (KURA)|Company Long-Term Debt ADC Therapeutics|FHTX: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities VOR (Vor Biopharma)|NKTX (nkartatx.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts ATNM (Actinium Pharmaceuticals Inc)|Estrella Immunopharma Corp - Company Long-Term Debt|CASI - Company Long-Term Debt|MRKR: Company Long-Term Debt|IN8bio (INAB) - Company Long-Term Debt|Long-Term Debt Eterna Therapeutics Inc. (ERNA)|Company Long-Term Debt GT Biopharma Corp|Long-Term Debt Aptose APTO|Company Long-Term Debts BPTH|meipharma.com - Company Long-Term Indebtedness|Company Long-Term Debts VINC (Vincerx Pharma)